A carregar...
Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras
Between December 2005 and October 2009, FDA approved six targeted therapies shown to significantly extend survival for advanced renal cell carcinoma (RCC) patients in clinical trials. This study aimed to examine changes in survival between the pretargeted and targeted therapy periods in advanced RCC...
Na minha lista:
Publicado no: | Cancer Med |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4735783/ https://ncbi.nlm.nih.gov/pubmed/26645975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.574 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|